COPD Exacerbation
Conditions
Brief summary
The aim of our study is to assess the feasibility and benefits of the implementation of an interactive telemonitoring system for earlier detection of COPD exacerbations in a community cohort preventing further deterioration requiring hospital admissions.
Interventions
OTHERExperimental
Patients will be every two weeks monitored by the researchers' team, taking into consideration lung function, symptoms, physical activity, pulse oximetry, body temperature, need for relief medication and Sputum characteristics. Over the 18 months, they will be the target of health education interventions, 2 individual and 2 in group.
Sponsors
GlaxoSmithKline
University of Minho
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of COPD * Aged 40 years or above * Must be enrolled in health centres from Braga
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Impact of the programme - % of retention of participating patients | 18 months | Measurement tool - questionnaire |
| Impact of COPD on patient's life using COPD Assessment Test (CAT) | 18 months | Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. |
| Impact of the programme - rate of compliance | 18 months | Measurement tool - questionnaire |
| Impact of the programme - satisfaction level | 18 months | Measurement tool - questionnaire |
| Number of COPD exacerbation with hospital admission | 18 months | — |
| Number of COPD exacerbation managed at home | 18 months | — |
| Quality of Life using St. George's Respiratory Questionnaire | 18 months | Scores range from 0 (no effect on quality of life) to a maximum score of 100 (maximum perceived distress). A higher score means a poorer quality of life |
Secondary
| Measure | Time frame |
|---|---|
| Dyspnoea level (mMRC) | 18 months |
| Changes in GOLD classification | 18 months |
| Pulmonary function (FEV1 and FEV1/ FVC ratio after BD) | 18 months |
Contacts
Primary ContactMaria João Barbosa, MD
Outcome results
None listed